Obbligazioni TEV
Di seguito è riportato l'elenco delle obbligazioni societarie TEVA PHARMACEUT. SP.ADR. Gli investitori spesso optano per le obbligazioni di una società per la loro maggiore stabilità in tempi di volatilità del mercato. Studia i prezzi, i rendimenti e altre statistiche per trovare un investimento affidabile.
Simbolo | YTM % | Volume | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
---|---|---|---|---|---|---|---|---|---|
TTEVA.GJTeva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026 | 26,91% | 2 K | 85,00% | 0,25% | 2026-02-01 | 22,88 M USD | 1.000,00 USD | 1.000,00 USD | Teva Pharmaceutical Finance Co. LLC |
TTFACTEVA P.FI.NL III 16/46 | 7,91% | 0 | 69,77% | 4,10% | 2046-10-01 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA4608603Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 6,96% | 1 M | 99,25% | 6,75% | 2028-03-01 | 255 K USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
UUS88163VAD1TEVA PHARM.FIN. 2036 | 6,09% | 0 | 100,41% | 6,15% | 2036-02-01 | 789,43 M USD | 1.000,00 USD | 2.000,00 USD | Teva Pharmaceutical Finance Co. LLC |
TTEVA6082388Teva Pharmaceutical Finance Netherlands III BV 6.0% 01-DEC-2032 | 5,71% | 5,6 M | 101,52% | 6,00% | 2032-12-01 | 500 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA5549924Teva Pharmaceutical Finance Netherlands III BV 8.125% 15-SEP-2031 | 5,57% | 7,2 M | 111,89% | 8,13% | 2031-09-15 | 500 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTFABTEVA P.FI.NL III 16/26 | 5,56% | 0 | 97,06% | 3,15% | 2026-10-01 | 1,8 B USD | 1.000,00 USD | 2.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA5549923Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029 | 5,53% | 400 K | 108,12% | 7,88% | 2029-09-15 | 397,68 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA4608604Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 5,43% | 1,03 M | 103,13% | 6,75% | 2028-03-01 | 1,25 B USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA6082389Teva Pharmaceutical Finance Netherlands IV BV 5.75% 01-DEC-2030 | 5,42% | 2,84 M | 101,40% | 5,75% | 2030-12-01 | 700 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands IV BV |
TTEVA5295245Teva Pharmaceutical Finance Netherlands III BV 5.125% 09-MAY-2029 | 5,36% | 1,93 M | 99,25% | 5,13% | 2029-05-09 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA5295244Teva Pharmaceutical Finance Netherlands III BV 4.75% 09-MAY-2027 | 5,33% | 1,01 M | 99,00% | 4,75% | 2027-05-09 | 649,12 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
CCH33382750TEVA PH.FI.NL IV 16-25 | 4,12% | 0 | 99,60% | 1,00% | 2025-07-28 | 350 M CHF | 5.000,00 CHF | 5.000,00 CHF | Teva Pharmaceutical Finance Netherlands IV BV |
XXS308179796TEV.P.F.N.II 25/31 | 3,99% | 0 | 100,63% | 4,13% | 2031-06-01 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS259280419TEV.P.F.N.II 23/31 | 3,90% | 0 | 120,03% | 7,88% | 2031-09-15 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS240660717TEV.P.F.N.II 21/30 | 3,80% | 0 | 102,39% | 4,38% | 2030-05-09 | 1,5 B EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS259280443TEV.P.F.N.II 23/29 | 3,63% | 0 | 113,84% | 7,38% | 2029-09-15 | 662,58 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS240660709TEV.P.F.N.II 21/27 | 3,37% | 0 | 100,69% | 3,75% | 2027-05-09 | 1,1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS121104407TEVA PH.F.NL.II 15/27 | 3,32% | 0 | 97,55% | 1,88% | 2027-03-31 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS143974936TEVA PH.F.NL.II 16/28 | 3,28% | 0 | 95,01% | 1,63% | 2028-10-15 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |